Experimental induction of apoptosis by a combination of etoposide and radiation treatment

Anticancer Research

Volumn 20, Issue 1 A, 2000, Pages 165-170

  Toda, Hisako ^a   Hasegawa, Masatoshi ^a   Hayakawa, Kayoko ^a   Kawashima, Miho ^a   Nakamura, Yuji ^a   Yamakawa, Michitaka ^a   Mitsuhashi, Norio ^a   Niibe, Hideo ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Etoposide; p53 protein; Radiation

Indexed keywords

ETOPOSIDE; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER TRANSPLANTATION; CONTROLLED STUDY; EPENDYMOBLASTOMA; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; X IRRADIATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BRAIN NEOPLASMS; DNA DAMAGE; DNA TOPOISOMERASES, TYPE II; DNA, NEOPLASM; ENZYME INHIBITORS; ETOPOSIDE; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NEUROECTODERMAL TUMORS, PRIMITIVE; SPECIFIC PATHOGEN-FREE ORGANISMS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034028126     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Anderson HJ and Roberge M: DNA topoisomerase II: a review of its involvement in chromosome structure, DNA replication,transcription and mitosis. Cell Biol Int Rep 16: 717-724, 1992.
2. Kaufmann SH: Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide,camptothecjn,and other cytotoxic anticancer drugs. Cancer Res 49: 5870-5878, 1989.
3. Lock RB, Galperina OV, Feldhoff RC and Rhodes LJ: Concentration-dependent differences in the mechanisms by which caffeinc potentiates etoposide cytotoxicity in HeLa cells. Cancer Res 54: 4933-4939, 1994.
4. Kalwinsky DK, Look AT, Ducore J and Fridland A: Effect of the epipodophyllotoxin VP-16-16-213 on cell cycle traverse, DNA synthesis and DNA strand size in cultures of human leukemic lymphoblasts. Cancer Res 43: 1592-1597, 1983.
5. Lock RB and Ross WE: Possible role for p34cdc2 kinase in etoposide-induced cell death of chinese hamster ovary cells. Cancer Res 50: 3767-3711, 1990.
6. Anderson H and Roberge M: Topoisomerase II inhibitors affect entry into mitosis and chromosome condensation in BHK cells. Cell Growth Differ 7: 83-90, 1996.
7. Greco FA: Future directions for etoposide therapy. Cancer 67: 315-318, 1990.
8. Turris AT: Thoracic radiotherapy variables: influence on local control in small cell lung cancer limited disease. Int J Radiat Oncol Biol Phys 19: 1473-1479, 1990.
9. Johnson DH, Hainsworth JD, Hande KR and Greco FA: Current status of etoposide in the management of small cell lung cancer. Cancer 67: 231-234, 1991.
10. Ohnishi H, Okada J, Yamaguchi M, Ogata H, Hatano K, Takizawa Y, Imai Y, Hara R and Araki T: Effect of daily administration of oral etoposide for non-small cell lung cancer treated with concurrent radiation therapy. Nippon Acta Radiologica 57: 510-514, 1997.
11. Hasegawa M, Mitsuhashi N, Yamakawa M, Furuta M, Maebayashi K, Imai R, Hayakawa K and Niibe H:p53 protein expression and radiation-induced apoptosis in human tumors transplanted to nude mice. Radiat Med 15: 171-176, 1997.
12. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849, 1993.
13. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace AJJ: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxiatelangiectasia. Cell 71: 587-597, 1992.
14. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849-852, 1993.
15. Strasser A, Harris AW, Jacks T and Cory S:DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibited by bel-2. Cell 79: 329-339, 1994.
16. Lowe SW, Ruley HE, Jacks T and Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967, 1993.
17. Skladanowski A and Larsen AK.: Expression of wild-type p53 increase etoposide cytotoxicity in MI myeloid leukemia cells by facilitated G2 to M transition: Implications for gene therapy. Cancer Res 57: 818-823, 1997.
18. Blagosklonny MV and El-Deiry WS.: Acute overexpression of wt p53 facilitates anticancer drug-induced death of cancer and normal cells. Int J Cancer 75: 933-940, 1998.
19. Macfarlane M, Jones NE, Dive C and Cohen GM:DNA-damaging agents induce both p53-dependent and p53-independent apoptosis in immature thymocytes. Mol Pharmacol 50: 900-911, 1996.
20. Malcomson RDG, Oren M, Wyllie AH and Harrison DJ: p53-independent death and p53-induced protection against apoptosis in fibroblasts treated with chemotherapeutic drugs. Br J Cancer 72: 952-957, 1995.
21. Blandino G, Levine AJ and Oren M:Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy. Oncogene 18: 477-485, 1999.
22. Brown JM and Wouters BG: Apoptosis, p53 and tumor cell sensitivity to anticancer agent. Cancer Res 59: 1391-1399, 1999.
23. Chen Z, Naito M, Mashima T and Tsuruo T: Activation of actin-cleavable interleukin 1β-converting enzyme(ICE) family protease CPP-32 during chemotherapeutic agent-induced apoptosis in ovarian carcinoma cells. Cancer Res 56: 5224-5229, 1996.
24. Milas L:Apoptosis:role in tumor growth and tumor therapy with radiation and other cytotoxic agents. Radiology 209(p)(supplement): 56-57, 1998.
25. Amundson SA, Myers TG and Fornace Jr AJ: Roles for p53 in growth arrest and apoptosis:putting on the brakes after genotoxic stress. Oncogene 17: 3287-3299, 1998.
26. Lee Jeon-UK, Hosotani R, Wada M, Doi R, Kosiba R, Fujimoto K, Miyamoto Y, Mori C, Nakamuru N, Shiota K and Imura M: Mechanism of apoptosis induced by cisplatin and VP-16 in PANC-1 cells. Anticancer Res 17: 3445-3450, 1997.